Wechselwirkungen · Rezolsta
REZOLSTA 600 mg/90 mg dispersible tablets · Abschnitt 4.5 · PDF-Seite 48
HOS-220560 · Präparat HOS-216626
Amitriptyline Based on theoretical Desipramine considerations REZOLSTA is Imipramine expected to increase these Nortriptyline anti-depressant plasma Trazodone concentrations. (CYP2D6 and/or CYP3A inhibition) ANTI-DIABETICS Metformin Based on theoretical Careful patient monitoring and considerations REZOLSTA is dose adjustment of metformin is expected to increase metformin recommended in patients who are plasma concentrations. taking REZOLSTA. (MATE1 inhibition) ANTIEMETICS Domperidone Not studied. Co-administration of domperidone with REZOLSTA is contraindicated. ANTIFUNGALS Clotrimazole Based on theoretical Caution is warranted and clinical Fluconazole considerations REZOLSTA is monitoring is recommended. Itraconazole expected to increase these Isavuconazole antifungal plasma concentrations, When co-administration is Posaconazole and darunavir and/or cobicistat required, the daily dose of plasma concentrations may be itraconazole should not exceed increased by the antifungals. 200 mg. (CYP3A inhibition and/or P-gp inhibition)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): isavuconazole (HOS-085186) nortriptyline (HOS-086245) amitriptyline (HOS-085911) desipramine (HOS-086249) imipramine (HOS-085907) clotrimazole (HOS-090574) domperidone (HOS-114656) itraconazole (HOS-084516) trazodone (HOS-086251) fluconazole (HOS-087945) posaconazole (HOS-085622) metformin (HOS-091032)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-08T17:33:00Z · SHA-256 fd4a09675891eba65ab2ce0a1cb84ffd3afbb1ff64ec7131830fe2eae67d87dc · Passage fb05a31249ea187a14921874e069882dfebfb0448c919808077399b7300a003b · Zeichen 21804–23381 im Abschnitt